4

$ABT · Abbott Laboratories

September 25, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Abbott Laboratories filed a Form 4 with the SEC reporting a change in beneficial ownership by director Kevin T. Conroy. The filing states that on September 23, 2026, Conroy disposed of 52,507 common shares without par value at a price of $103.99 per share. The transaction code indicates this was a payment of exercise price or tax liability by delivering or withholding securities, rather than an open-market sale described in the filing.

Following the reported transaction, Conroy directly beneficially owns 81,230 Abbott common shares. The report shows no acquisitions of common shares and no transactions involving derivative securities such as options, warrants, or convertible securities during the period covered by the filing. The form was signed on September 25, 2026, by an attorney-in-fact on behalf of Conroy.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →